Form 4: Butterfly Network CFO Awarded Performance Equity

Sentiment:

Executive Equity Grant


Butterfly Network's EVP and CFO, John N. Doherty, was granted over 1.2 million shares of Class A Common Stock, including performance-based restricted stock units tied to future stock price targets.

Summary

  • John N. Doherty, EVP, CFO of Butterfly Network, Inc. (BFLY), acquired 1,294,870 shares of Class A Common Stock through restricted stock unit (RSU) grants on December 8, 2025.
  • This includes 863,247 time-based RSUs that vest over three years, with one-third vesting on December 8, 2026, and the remainder annually thereafter, contingent on continued service.
  • An additional 431,623 performance-based RSUs were granted, which vest in three equal tranches upon the company's Class A Common Stock achieving closing prices of $3.00, $4.50, and $6.00 per share for 20 consecutive trading days.
  • These performance targets must be met by December 8, 2030, and are also subject to Mr. Doherty's continued service.
  • The reported acquisition price for both RSU grants was $0 per share.
  • Following these transactions, Mr. Doherty beneficially owns 1,294,870 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The equity grant, particularly the performance-based component, strongly aligns the EVP, CFO's incentives with increasing shareholder value through specific stock price targets. This is generally viewed positively as it motivates management to drive company performance. However, it also represents potential future dilution.

Positives

  • The grant of performance-based RSUs directly aligns the EVP, CFO's interests with shareholder value creation, incentivizing stock price appreciation.
  • The multi-year vesting schedule for standard RSUs promotes long-term retention of a key executive.
  • The specific stock price targets ($3.00, $4.50, $6.00) provide clear, measurable goals for management, signaling a strategic focus on growth.

Negatives

  • The RSU grants represent potential future dilution for existing shareholders as shares are issued upon vesting.
  • The $0 acquisition price for the RSUs means the executive receives shares without direct cash outlay, which could be viewed negatively by some investors if performance targets are not met.

Risks

  • Forfeiture Risk: The RSUs are subject to forfeiture if the reporting person's service terminates before the applicable vesting dates.
  • Performance Target Risk: The performance-based RSUs may not vest if the company's stock price does not achieve the specified targets ($3.00, $4.50, $6.00) within the timeframe ending December 8, 2030.
  • Dilution Risk: The issuance of shares upon vesting of RSUs will dilute the ownership percentage of existing shareholders.

Future Outlook

The future outlook for a portion of the EVP, CFO's compensation is directly tied to the company's ability to achieve specific stock price targets of $3.00, $4.50, and $6.00 per share by December 8, 2030, indicating a strategic focus on increasing shareholder value.

Industry Context

The grant of performance-based equity to a key executive like the CFO is a common practice in the technology and medical device industries, particularly for growth-oriented companies like Butterfly Network. This structure aims to align executive incentives with long-term shareholder value creation and is often seen as a competitive compensation strategy to attract and retain top talent.

Comparison to Industry Standards

  • Performance-based equity awards with specific stock price hurdles are a standard component of executive compensation packages across various industries, including medical technology.
  • Similar structures are observed in companies like Inari Medical (NARI) or Shockwave Medical (SWAV) where executive compensation often includes significant equity components tied to operational and stock performance.
  • The multi-tiered price targets ($3.00, $4.50, $6.00) are designed to incentivize sustained growth, a common approach seen in high-growth sectors.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PolicyGrant of restricted stock units (RSUs) and performance-based RSUs to the EVP, CFO, aligning executive incentives with shareholder value creation.12/08/2025Enhances alignment between executive compensation and company performance, potentially motivating efforts to achieve stock price targets. Introduces potential future share dilution.

Related Party Transactions

  • The grant of equity compensation to an executive officer (John N. Doherty, EVP, CFO) is a related party transaction, aligning executive incentives with company performance.

Stakeholder Impact

  • Shareholders: Potential for increased shareholder value if performance targets are met, but also potential for dilution upon vesting of RSUs.
  • Employees: Retention and motivation of a key executive (CFO) through long-term incentives.
  • Management: Strong incentive to drive stock price performance and ensure continued service.

Next Steps

  • Achievement of Class A Common Stock price targets of $3.00, $4.50, and $6.00 for 20 consecutive trading days to trigger vesting of performance-based RSUs.
  • Continued service of John N. Doherty through vesting dates for both time-based and performance-based RSUs.
  • Annual vesting of time-based RSUs over the next two years following December 8, 2026.

Key Dates

DateDescription
12/08/2025Date of RSU grants to John N. Doherty.
12/08/2026First vesting date for one-third of the time-based restricted stock units.
12/08/2030Deadline for achieving stock price targets for performance-based restricted stock units.

Keywords

BFLY, Butterfly Network, RSU, equity grant, executive compensation, CFO, performance shares, insider transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.